13F-HR filed by Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 89 holding rows worth $709,942,650.
- Accession
- 0001420506-24-000380
- Filer
- CIK 1777015
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 89 entries on the cover page, a total value of $709,942,650 stated on the cover page (in dollars after the unit check, H1), rows summing to $709,942,650 with VALUE read as dollars as filed, 13F file number 028-19992. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 101137107 | COM | 652,803 | $37,738,541 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 161,539 | $35,520,811 | dollars as filed | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 75,183 | $28,452,255 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 225,615 | $27,996,565 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 356,806 | $26,963,829 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 102,891 | $21,131,754 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 103,746 | $21,105,049 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 513,032 | $20,685,450 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 88,675 | $19,240,702 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 140,116 | $18,461,684 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 61,524 | $17,720,142 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 156,727 | $17,250,941 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 267,594 | $16,804,903 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 67,458 | $16,448,284 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 738,589 | $15,960,908 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 405,232 | $14,507,306 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 360,467 | $14,332,168 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 294,788 | $13,577,935 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 186,272 | $13,340,801 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 250,000 | $10,857,500 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 615,693 | $10,799,255 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 211,400 | $10,694,726 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 504,742 | $10,034,271 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 168,262 | $9,338,541 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,018,812 | $9,159,120 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 625,749 | $9,135,935 | dollars as filed | |
| METTLER TOLEDO INTERNATIONAL COM | 592688105 | Stock | 7,500 | $9,097,200 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 2,498,624 | $9,094,991 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 561,025 | $9,049,333 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 18,081 | $8,277,663 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 357,156 | $7,707,426 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 240,000 | $7,545,600 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 651,625 | $7,128,778 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 167,001 | $6,873,761 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 545,235 | $6,690,033 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 237,316 | $6,528,563 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 69,940 | $5,980,569 | dollars as filed | |
| AUGMEDIX INC | 05105P107 | COM | 1,015,814 | $5,942,512 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 312,889 | $5,657,033 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 529,877 | $5,399,447 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 92,871 | $5,364,229 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 10,000 | $5,307,900 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,202,431 | $5,158,429 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 100,000 | $5,131,000 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 80,000 | $4,960,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 82,009 | $4,952,524 | dollars as filed | |
| PERFORMANT HEALTHCARE INC | 71377E105 | COM | 1,580,865 | $4,940,203 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 247,664 | $4,730,382 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 150,816 | $4,673,788 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 130,265 | $4,634,829 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 59,867 | $4,405,613 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 157,817 | $4,339,968 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 120,652 | $4,292,798 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,425,204 | $4,261,360 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 100,734 | $4,066,632 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 232,942 | $4,046,203 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 146,366 | $4,001,646 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 754,885 | $3,955,597 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 237,762 | $3,846,989 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 253,947 | $3,550,179 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 205,317 | $3,506,814 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 119,417 | $3,455,928 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,019,156 | $3,414,173 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 300,750 | $3,359,378 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 674,787 | $3,292,961 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 50,000 | $3,130,000 | dollars as filed | put |
| SI BONE INC | 825704109 | COM | 145,575 | $3,055,619 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 175,500 | $2,632,500 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 429,892 | $2,592,249 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 219,448 | $2,451,234 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 603,497 | $2,317,428 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 890,099 | $2,251,950 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 696,470 | $1,622,775 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 38,678 | $1,576,515 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 120,652 | $1,380,259 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 603,620 | $1,334,000 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 87,678 | $1,248,535 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 101,767 | $1,224,257 | dollars as filed | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 282,236 | $1,052,740 | dollars as filed | |
| SOPHIA GENETICS SA | H82027105 | ORDINARY SHARES | 199,997 | $941,986 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 212,432 | $904,960 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 199,168 | $872,356 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 253,717 | $712,945 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 103,375 | $684,343 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 65,679 | $650,222 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 767,332 | $643,408 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 96,837 | $569,402 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 102,256 | $153,384 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 110,658 | $57,775 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000380 | this filing | 2024-02-14 | acceptance time not in the bulk data set |